GSK - A CASE STUDY ON THE STRATEGY OF “MERGER OF EQUALS” IN ETHICAL PHARMACEUTICALS
Industrial Organization from EconWPA
This case summarises events leading to the creation of a global giant. The merger of Glaxo Wellcome and SmithKline Beecham had implications that went beyond the UK, where both companies were domiciled. The new company sought to take residence in the US but anti-trust authorities kept the companies formally apart for more than a year as they examined every aspect of the deal. The case invites readers to consider the process of integration as a general strategy, as well as the expectations, deliberations and motivation of managers and shareholders in doing so.
JEL-codes: L (search for similar items in EconPapers)
New Economics Papers: this item is included in nep-com, nep-hea, nep-his and nep-ind
Note: Type of Document - pdf; to print on HP/PostScript/Franciscan monk; pages: 16
References: Add references at CitEc
Citations Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:wpa:wuwpio:0211017
Access Statistics for this paper
More papers in Industrial Organization from EconWPA
Series data maintained by EconWPA ().